This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Sysco (SYY) Q1 Earnings Top Estimates, Volume Gains a Driver
by Zacks Equity Research
Sysco's (SYY) first-quarter results reflect sales and earnings growth due to higher volumes, robust margin management and efficient productivity enhancements.
Celsius Holdings Inc. (CELH) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celsius Holdings Inc. (CELH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?
by Zacks Equity Research
e.l.f. Beauty's (ELF) strong business fundamentals, strategic acquisitions, focus on innovation and international expansion position it favorably ahead of its Q2 earnings release.
FEMSA (FMX) Q3 Earnings Beat, Revenues Lag Estimates
by Zacks Equity Research
FEMSA's (FMX) Q3 results reflect gains from strong top-line growth across its business units, gross margin expansion and the inclusion of Proximity Europe.
These 3 Top-Ranked Companies Boast Robust Sales Growth
by Derek Lewis
On top of robust revenue growth, all three have seen positive earnings estimate revisions, reflecting optimism among analysts.
Colgate (CL) Beats Q3 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Colgate-Palmolive's (CL) third-quarter 2023 organic sales advance 9% y/y, with improvements in the majority of divisions and categories.
Hershey's (HSY) Q3 Earnings Top Estimates, Sales Grow Y/Y
by Zacks Equity Research
Hershey's (HSY) third-quarter 2023 results reflect improved earnings and net sales on net price realization and volume gain.
Medifast (MED) Poised on Expansion Initiatives Amid Cost Woes
by Zacks Equity Research
Medifast (MED) is making significant strides in its digital transformation efforts and expanding its OPTAVIA lifestyle solution to meet the increasing demand in the health and wellness market.
Here's Why Hormel Foods' (HRL) Stock Plummeted 32% YTD
by Zacks Equity Research
Hormel Foods (HRL) operates in a volatile, complex and inflationary landscape. Weakness in the International segment is a hurdle.
Celsius Holdings Inc. (CELH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Celsius Holdings Inc. (CELH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNY
Are Consumer Staples Stocks Lagging Celsius (CELH) This Year?
by Zacks Equity Research
Here is how Celsius Holdings Inc. (CELH) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
Casey's (CASY) Shares Up 19.7% YTD: What's Driving the Stock?
by Zacks Equity Research
Casey's' (CASY) strategic initiatives, solid omnichannel capabilities and private-label offerings strengthen its prominent position in the convenience store industry.
Beat the Market the Zacks Way: Novo Nordisk, MakeMyTrip, Fastenal in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RFG
Solid Demand Trends to Aid Procter & Gamble's (PG) Q1 Earnings
by Zacks Equity Research
Procter & Gamble (PG) Q1 results are expected to reflect gains from strong top -line growth, improved cost-productivity and solid consumer demand, partly offset by higher costs and currency headwinds.
Celsius Holdings Inc. (CELH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Celsius Holdings Inc. (CELH) closed at $165.75 in the latest trading session, marking a -0.77% move from the prior day.
Why Celsius Holdings Inc. (CELH) Could Beat Earnings Estimates Again
by Zacks Equity Research
Celsius Holdings Inc. (CELH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Mondelez (MDLZ) Appears Appetizing, Gains More Than 15% in a Year
by Zacks Equity Research
Mondelez (MDLZ) gains from its prudent acquisitions and divestitures to emphasize core areas. Proactive pricing strategies aid amid cost inflation.
Pricing Actions Aid B&G Foods (BGS), Lower Volumes Ail
by Zacks Equity Research
B&G Foods' (BGS) efficient pricing protects margins amid an inflationary environment. However, the company is struggling with lower volume.
Zacks Industry Outlook Highlights The Kraft Heinz, Lamb Weston, Celsius and Post
by Zacks Equity Research
The Kraft Heinz, Lamb Weston, Celsius and Post are part of the Zacks Industry Outlook article.
4 Food Stocks Poised to Gain on Prospering Industry Trends
by Avisekh Bhattacharjee
The Zacks Food-Miscellaneous industry participants gain from solid at-home consumption, product innovations and pricing actions. Kraft Heinz Company (KHC), Lamb Weston (LW), Celsius Holdings (CELH) and Post Holdings (POST) are notable stocks in the industry.
These 3 Quarterly Releases Could Surprise the Market
by Derek Lewis
Earnings season is always an exciting period for investors, with companies finally pulling the curtain back and unveiling what's transpired behind the scenes.
Helen of Troy (HELE) Q2 Earnings Top Estimates, Reaffirms View
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2024 results reflect a decline in earnings and sales due to lower consumer demand for certain product categories.